Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
05/2004
05/13/2004WO2004039768A1 Bifunctional phenyliso(thio)cyanates; method and intermediate products for the production thereof
05/13/2004WO2004039766A1 Phenylethanolamine derivatives for the treatment of respiratory diseases
05/13/2004WO2004039764A1 Novel amide compounds with mch antagonistic effect and medicaments comprising said compounds
05/13/2004WO2004039753A2 Phenyl compounds
05/13/2004WO2004039155A1 3-benzoyl-2,4,5-substituted pyridine derivatives or salts thereof and bactericides containing the same
05/13/2004WO2004026305A9 Diaryl ethers as opioid receptor antagonist
05/13/2004WO2004022529A3 Diarylurea derivatives and their use as chloride channel blockers
05/13/2004US20040092747 Amide compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
05/13/2004US20040092741 Substituted pyridines via boronic acid coupling
05/13/2004US20040092728 Using halodimethylsulfonium halide as activated nucleophilic agent
05/13/2004US20040092687 Polymeric charge transport compositions and electronic devices made with such compositions
05/13/2004US20040092598 Antiproliferative agnets; anticancer agents; skin disorders
05/13/2004US20040092596 2-Aryloxy-2arylalkanoic acids for diabetes and lipid disorders
05/13/2004US20040092557 Aliphatic amino-substituted demethoxylated hypocrellins and their synthesis
05/13/2004US20040092556 Aids therapy
05/13/2004US20040092553 Excitatory amino acid receptor modulators
05/13/2004US20040092538 Cycloalkyl alkanoic acids as integrin receptor antagonists derivatives
05/13/2004US20040092521 Antihistamines; central nervous system disorders
05/13/2004US20040092518 Compounds for the treatment of metabolic disorders
05/13/2004US20040092517 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours
05/13/2004US20040092516 Insulin resistance; antidiabetic agents; antilipemic agents; anticholesterol agents; cardiovascular disorders
05/13/2004US20040092508 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
05/13/2004US20040092506 Administering estrogen antagonist; skin disorders; wrinkle resistance; antiarthritic agents; anticancer agents; wound healing agents
05/13/2004US20040092497 Heteroarylakanoic acids as intergrin receptor antagonists
05/13/2004US20040092454 3-biphenyl-4-yl-3-(2-(4-(pyridin-2-ylamino)pentanoylamino)-pen tanoyl amino)propionic acid derivatives
05/13/2004US20040092401 Plant safening agents
05/13/2004US20040091951 Assay for measuring acetylation or deacetylation activity of an enzyme
05/13/2004US20040091407 Novel process for preparing crystalline particles of a salt of a substance, particularly particles of therapeutically useful or carrier substances of a size suitable for inhalation therapy.
05/13/2004US20040089867 Electroluminescent iridium compounds with fluorinated phenylpryidines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
05/13/2004US20040088804 Novel reactive dyes and the use thereof for dyeing substrates containing nucleophilic groups
05/13/2004CA2502959A1 Metal chelates and methods of using them for time-resolved fluorescence
05/12/2004EP1417200A2 Substituted 1h-dihydropyrazoles, their preparation and use
05/12/2004EP1417190A1 Substituted piperazines as modulators of the melanocortin receptor
05/12/2004EP1417175A1 Substituted dihydro 3-halo-1h-pyrazole-5-carboxylates, their preparation and use
05/12/2004EP1417173A1 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands
05/12/2004EP1417172A1 Process for the preparation of amorphous form of torsemide
05/12/2004EP1416928A2 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents
05/12/2004EP1416797A1 Arthropodicidal anthranilamides
05/12/2004EP1416796A1 Method for controlling particular insect pests by applying anthranilamide compounds
05/12/2004EP1341785A4 HYDROLYSIS OF R(R*,R*)]-2-(4-FLUOROPHENYL)-$g(b),$g(d) -DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4- (PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE
05/12/2004EP1165485B1 Processes for preparing pesticidal intermediates
05/12/2004EP1163208B1 Caspase inhibitors and uses thereof
05/12/2004EP1102592B1 Coumarin and related aromatic-based polymeric prodrugs
05/12/2004EP1069898B1 Topical antiseptic compositions and methods
05/12/2004EP1066316B1 Cinnamic acid derivatives having cell adhesion modulating activity
05/12/2004EP1052984B1 Antibacterial agents
05/12/2004EP1028111B1 Amide derivatives or salts thereof
05/12/2004EP0996616B1 Process and a novel intermediate for the preparation of flecainide
05/12/2004EP0923371B1 Pharmaceutical compositions comprising tyrphostins
05/12/2004CN1496388A Pyridone dyes, a process for their preparation and their use in production of colorued plastics or polymeric colour particles
05/12/2004CN1496260A Method for increasing leptin levels using nicotinic acid compounds
05/12/2004CN1495169A Pyridine-3-carboxylic acid derivative
05/12/2004CN1495168A Intermediate for preparing pesticide
05/12/2004CN1494903A Preventing or curing agent for eye fatigue and pseudomyopia
05/12/2004CN1149199C Niacinamide prepn. method
05/12/2004CN1149198C Improved pyridine/picoline production process
05/12/2004CN1149196C Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
05/11/2004US6734309 Process for the synthesis of isonicotinic acid hydrazide
05/11/2004US6734303 Therapy for benign prostatic hyperplasia
05/11/2004US6734207 For inhibiting the proliferation of tumor cells; as anticancer agent
05/11/2004US6734203 Fused imidazolium derivatives
05/11/2004US6734196 Substituted pyridine or piperidine compounds
05/11/2004US6734191 Chemokine receptor binding heterocyclic compounds
05/11/2004US6734186 Phosphodiesterase 2 inhibitor
05/11/2004US6734184 Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP)
05/11/2004US6734183 Useful as metalloproteinase inhibitor; piperazino-sulfonamide or piperidino-sulfonamide compound
05/11/2004US6734143 2-methoxyimino-2(pyridinyloxymethyl)phenyl acetamides useful as fungicides
05/11/2004US6733905 Metal coordination compound, luminescence device and display apparatus
05/11/2004US6733690 Acrylic ester polymers
05/06/2004WO2004038374A2 Alkyne derivatives as tracers for metabotropic glutamate receptor binding
05/06/2004WO2004037808A1 2 - substituted heterocyclic compounds and antitumor composition comprising the same
05/06/2004WO2004037800A1 Aryloxyalkylamine derivates as h3 receptor ligands
05/06/2004WO2004037791A1 Inhibitors of glycogen synthase kinase 3
05/06/2004WO2004037790A1 Process for the preparation of aryl-piridyl compounds
05/06/2004WO2004037789A2 Methylene urea derivatives as raf-kinase inhibitors
05/06/2004WO2004037773A1 Phenethanolamine derivative for the treatment of respiratory diseases
05/06/2004WO2004037415A2 Catalyst systems for ethylene oligomerisation to linear alpha olefins
05/06/2004WO2004004715A3 Novel delta opioid receptor ligands
05/06/2004WO2003097604A9 Pyridine carboxamide derivatives and their use as pesticides
05/06/2004WO2003091228A3 Method for producing substituted phenylsulfonyl urea
05/06/2004WO2003082853A8 New compounds
05/06/2004WO2003051894A8 Preparation of ionic liquids
05/06/2004WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/06/2004US20040087799 Process for the preparation of vinylpyridine from picoline over modified zeolites
05/06/2004US20040087798 Novel amide compounds
05/06/2004US20040087792 Tryptase-inhibitors
05/06/2004US20040087791 Bis(substituted propynyl)-substituted benzenes, pyridines, pyrimidines, pyrazines, pyridines, furans and pyrroles; e.g., 3,5-bis-(3-(4-aminomethylbenzylaminocarbonyloxy)prop-1-ynyl)--1 -hydroxymethylbenzene
05/06/2004US20040087657 Treatment of neurodegenerative diseases and cancer of the brain using histone deacetylase inhibitors
05/06/2004US20040087650 Inhibitors of IMPDH enzyme
05/06/2004US20040087640 Administering by mouth; cyclooxygenase inhibitor; controlling particle size
05/06/2004US20040087632 Controlling metabolism of lipids, cholesterol
05/06/2004US20040087627 Decarboxylase inhibitors; cardiovascular diosrders; antidiabetic agents; anticancer agents; dietetics
05/06/2004US20040087620 Terphenyl compounds bearing substituted amino groups
05/06/2004US20040087604 Immunosuppressants; antiallergens
05/06/2004US20040087591 Phosphodiesterase inhibitors and nitric oxide donors, compositions and methods of use
05/06/2004US20040087590 Novel biphenyl and biphenyl-like cannabinoids
05/06/2004US20040087585 Peptide deformylase inhibitors
05/06/2004US20040087583 Kinase inhibitors; antiinflammatory agents; autoimmune diseases; anticancer agents
05/06/2004US20040087582 Anticaogulants; cardiovascular disorders; Factor x inhibitors; antiinflammatory agents
05/06/2004US20040087577 Anti-infective agents